Comparative Pharmacology
Head-to-head clinical analysis: AVAGARD versus HIBISTAT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AVAGARD versus HIBISTAT.
AVAGARD vs HIBISTAT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Avagard (chlorhexidine gluconate 1% and isopropyl alcohol 61%) is an antiseptic with bactericidal activity. Chlorhexidine disrupts cell membranes and precipitates cell contents; isopropyl alcohol denatures proteins and dissolves lipids.
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. Active against susceptible gram-positive bacteria.
Chlorhexidine gluconate 2% + isopropyl alcohol 70% solution: apply 5 mL to each hand and forearm, rub vigorously for 2-3 minutes, allow to dry; repeat once. For surgical hand antisepsis: apply 5 mL to hands and forearms, scrub for 3 minutes, rinse, repeat.
1.5 mg/kg intravenously every 6 hours; maximum 120 mg per dose.
None Documented
None Documented
Terminal elimination half-life is 4-6 hours in patients with normal renal function; prolonged to 18-24 hours in severe renal impairment (CrCl <30 mL/min).
Terminal elimination half-life is 2.5–3.5 hours in patients with normal renal function; prolonged in renal impairment, requiring dose adjustment.
Primarily renal (unchanged drug and metabolites) with approximately 20-30% excreted fecally; renal clearance accounts for >60% of total clearance.
Approximately 90% of absorbed dose excreted renally as unchanged drug; <5% in feces via biliary elimination.
Category C
Category C
Antiseptic
Antiseptic